Why the study?
Do elevated plasma inflammatory markers and diabetes predict clopidogrel resistance in patients after percutaneous coronary intervention?
Do elevated plasma inflammatory markers and diabetes predict clopidogrel resistance in patients after percutaneous coronary intervention?
Elevated sCD40L levels and diabetes are independent predictors of clopidogrel resistance at 6 months following percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Should not yet change post-PCI antiplatelet selection; leaves open whether targeting diabetes or sCD40L improves responsiveness.
Ge et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: